Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9625, pp. 1695 - 1709
Summary Most head and neck cancers are squamous cell carcinomas that develop in the upper aerodigestive epithelium after exposure to carcinogens such as...
Internal Medicine | PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | 2ND PRIMARY TUMORS | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | LOCOREGIONALLY ADVANCED HEAD | QUALITY-OF-LIFE | HUMAN-PAPILLOMAVIRUS | CISPLATIN PLUS FLUOROURACIL | RADIATION-THERAPY | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Risk Factors | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Male | Combined Modality Therapy | Head and Neck Neoplasms - pathology | Randomized Controlled Trials as Topic | Carcinoma, Squamous Cell - etiology | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Head and Neck Neoplasms - etiology | Female | Signal Transduction - physiology | Head and neck cancer | Development and progression | Care and treatment | Squamous cell carcinoma | Diagnosis | Laryngeal cancer | Colorectal cancer | Oncology | Histology | Radiation therapy | Gene expression | Patients | Disease control | Risk factors | Clinical outcomes | Alcohol use | Human papillomavirus | Chemotherapy | Larynx | Head & neck cancer | Index Medicus | Abridged Index Medicus
Internal Medicine | PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | 2ND PRIMARY TUMORS | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | LOCOREGIONALLY ADVANCED HEAD | QUALITY-OF-LIFE | HUMAN-PAPILLOMAVIRUS | CISPLATIN PLUS FLUOROURACIL | RADIATION-THERAPY | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Risk Factors | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Male | Combined Modality Therapy | Head and Neck Neoplasms - pathology | Randomized Controlled Trials as Topic | Carcinoma, Squamous Cell - etiology | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Head and Neck Neoplasms - etiology | Female | Signal Transduction - physiology | Head and neck cancer | Development and progression | Care and treatment | Squamous cell carcinoma | Diagnosis | Laryngeal cancer | Colorectal cancer | Oncology | Histology | Radiation therapy | Gene expression | Patients | Disease control | Risk factors | Clinical outcomes | Alcohol use | Human papillomavirus | Chemotherapy | Larynx | Head & neck cancer | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1221 - 1237
The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed that altered fractionation radiotherapy is associated with...
PHASE-III TRIAL | PROSPECTIVE RANDOMIZED-TRIAL | ONCOLOGY | ACCELERATED RADIATION-THERAPY | CONVENTIONAL RADIOTHERAPY | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | MEAN SURVIVAL-TIME | INDIVIDUAL PATIENT DATA | LOCOREGIONALLY ADVANCED-CARCINOMA | CONCOMITANT BOOST RADIOTHERAPY | Head and Neck Neoplasms - radiotherapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Dose Fractionation, Radiation | Carcinoma, Squamous Cell - pathology | Humans | Head and Neck Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Head and Neck Neoplasms - pathology | Radiotherapy | Analysis | Cancer | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
PHASE-III TRIAL | PROSPECTIVE RANDOMIZED-TRIAL | ONCOLOGY | ACCELERATED RADIATION-THERAPY | CONVENTIONAL RADIOTHERAPY | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | MEAN SURVIVAL-TIME | INDIVIDUAL PATIENT DATA | LOCOREGIONALLY ADVANCED-CARCINOMA | CONCOMITANT BOOST RADIOTHERAPY | Head and Neck Neoplasms - radiotherapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Dose Fractionation, Radiation | Carcinoma, Squamous Cell - pathology | Humans | Head and Neck Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Head and Neck Neoplasms - pathology | Radiotherapy | Analysis | Cancer | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Cancer, ISSN 0008-543X, 10/2008, Volume 113, Issue 7, pp. 1911 - 1932
Since the inception Of this journal in 1948, the understanding of etiologic factors that contribute to and the treatment of head and neck cancer has evolved...
Combined modality therapy | Head and neck surgery | Radiation therapy | Neck dissection | Head and neck Cancer | Concurrent chemotherapy | Head and neck squamous cell carcinoma (HNSCC) | SQUAMOUS-CELL-CARCINOMA | concurrent chemotherapy | head and neck cancer | head and neck squamous cell carcinoma (HNSCC) | THERAPY-ONCOLOGY-GROUP | head and neck surgery | UPPER AERODIGESTIVE TRACT | ADVANCED LARYNGEAL-CANCER | LYMPH-NODE METASTASES | MODULATED RADIATION-THERAPY | GROWTH-FACTOR RECEPTOR | ONCOLOGY | radiation therapy | combined modality therapy | neck dissection | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | HUMAN-PAPILLOMAVIRUS INFECTION | Lymph Node Excision | Head and Neck Neoplasms - etiology | Humans | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Combined Modality Therapy | Neck | Radical neck dissection | Care and treatment | Chemotherapy | Usage | Head and neck cancer | Forecasts and trends | Cancer
Combined modality therapy | Head and neck surgery | Radiation therapy | Neck dissection | Head and neck Cancer | Concurrent chemotherapy | Head and neck squamous cell carcinoma (HNSCC) | SQUAMOUS-CELL-CARCINOMA | concurrent chemotherapy | head and neck cancer | head and neck squamous cell carcinoma (HNSCC) | THERAPY-ONCOLOGY-GROUP | head and neck surgery | UPPER AERODIGESTIVE TRACT | ADVANCED LARYNGEAL-CANCER | LYMPH-NODE METASTASES | MODULATED RADIATION-THERAPY | GROWTH-FACTOR RECEPTOR | ONCOLOGY | radiation therapy | combined modality therapy | neck dissection | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | HUMAN-PAPILLOMAVIRUS INFECTION | Lymph Node Excision | Head and Neck Neoplasms - etiology | Humans | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Combined Modality Therapy | Neck | Radical neck dissection | Care and treatment | Chemotherapy | Usage | Head and neck cancer | Forecasts and trends | Cancer
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 06/2011, Volume 9, Issue 6, pp. 596 - 649
head and neck cancer | STANDARD FRACTIONATION RADIOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | NCCN Clinical Practice Guidelines | chemotherapy | larynx | PHASE-II TRIAL | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | NCCN Guidelines | radiotherapy | oral cavity | supraglottic | SQUAMOUS-CELL CARCINOMA | METASTATIC NASOPHARYNGEAL CARCINOMA | hypopharynx | LOCALLY ADVANCED HEAD | glottic | QUALITY-OF-LIFE | oropharynx | nasopharynx | CISPLATIN PLUS FLUOROURACIL | POSTOPERATIVE RADIATION-THERAPY | surgery | Head and Neck Neoplasms - radiotherapy | Humans | Head and Neck Neoplasms - therapy | Medical Oncology - standards | Patient Care Team | Quality of Life | Neoplasm Staging | Head and Neck Neoplasms - surgery | Head and Neck Neoplasms - pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 11, pp. 1143 - 1154
There are more than half a million incident cases of squamous-cell carcinoma of the head and neck worldwide each year, primarily affecting the oropharynx, oral...
MODULATED RADIATION-THERAPY | MEDICINE, GENERAL & INTERNAL | GROWTH-FACTOR-RECEPTOR | LYMPH-NODE METASTASIS | MULTICENTER PHASE-II | SQUAMOUS-CELL CARCINOMA | DEPENDENT PROTEIN-KINASE | LOCALLY ADVANCED HEAD | UPPER AERODIGESTIVE TRACT | HUMAN-PAPILLOMAVIRUS | OROPHARYNGEAL CARCINOMA | Genomic Instability | Papillomavirus Infections - complications | Signal Transduction | Humans | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Head and Neck Neoplasms - physiopathology | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Radiotherapy | Carcinoma, Squamous Cell - physiopathology | Disease Progression | Antibodies, Monoclonal, Humanized | Human papillomavirus 16 | Carcinoma, Squamous Cell - etiology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Head and Neck Neoplasms - etiology | Cetuximab | Receptor, Epidermal Growth Factor - physiology
MODULATED RADIATION-THERAPY | MEDICINE, GENERAL & INTERNAL | GROWTH-FACTOR-RECEPTOR | LYMPH-NODE METASTASIS | MULTICENTER PHASE-II | SQUAMOUS-CELL CARCINOMA | DEPENDENT PROTEIN-KINASE | LOCALLY ADVANCED HEAD | UPPER AERODIGESTIVE TRACT | HUMAN-PAPILLOMAVIRUS | OROPHARYNGEAL CARCINOMA | Genomic Instability | Papillomavirus Infections - complications | Signal Transduction | Humans | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Head and Neck Neoplasms - physiopathology | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Radiotherapy | Carcinoma, Squamous Cell - physiopathology | Disease Progression | Antibodies, Monoclonal, Humanized | Human papillomavirus 16 | Carcinoma, Squamous Cell - etiology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Head and Neck Neoplasms - etiology | Cetuximab | Receptor, Epidermal Growth Factor - physiology
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2011, Volume 100, Issue 1, pp. 22 - 32
Abstract Background: The importance of tumour hypoxia for the outcome of radiotherapy has been under investigation for decades. Numerous clinical trials...
Hematology, Oncology and Palliative Medicine | Hypoxic sensitizer | Head and neck cancer | Hypoxic modification | Hyperbaric oxygen | Meta-analysis | HYPERBARIC-OXYGEN | PHARYNX CARCINOMA | DAHANCA PROTOCOL 5-85 | RANDOMIZED CLINICAL-TRIAL | MISONIDAZOLE-SENSITIZED RADIOTHERAPY | RADIATION-THERAPY | PHASE-III TRIAL | ONCOLOGY | FRACTIONATED RADIOTHERAPY | LOCALLY ADVANCED HEAD | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Head and Neck Neoplasms - radiotherapy | Neoplasm Metastasis | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Carcinoma, Squamous Cell - pathology | Humans | Radiotherapy - adverse effects | Head and Neck Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Head and Neck Neoplasms - pathology | Hypoxia - metabolism
Hematology, Oncology and Palliative Medicine | Hypoxic sensitizer | Head and neck cancer | Hypoxic modification | Hyperbaric oxygen | Meta-analysis | HYPERBARIC-OXYGEN | PHARYNX CARCINOMA | DAHANCA PROTOCOL 5-85 | RANDOMIZED CLINICAL-TRIAL | MISONIDAZOLE-SENSITIZED RADIOTHERAPY | RADIATION-THERAPY | PHASE-III TRIAL | ONCOLOGY | FRACTIONATED RADIOTHERAPY | LOCALLY ADVANCED HEAD | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Head and Neck Neoplasms - radiotherapy | Neoplasm Metastasis | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Carcinoma, Squamous Cell - pathology | Humans | Radiotherapy - adverse effects | Head and Neck Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Head and Neck Neoplasms - pathology | Hypoxia - metabolism
Journal Article
Journal of the National Comprehensive Cancer Network : JNCCN, ISSN 1540-1405, 06/2017, Volume 15, Issue 6, pp. 761 - 770
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral...
POSTOPERATIVE CHEMORADIATION | CRITICAL-APPRAISAL | ONCOLOGY | OROPHARYNGEAL CANCER | EXTRACAPSULAR SPREAD | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | HUMAN-PAPILLOMAVIRUS | PROGNOSTIC-SIGNIFICANCE | METASTATIC HEAD | NEGATIVE HEAD | Head and Neck Neoplasms - diagnosis | Head and Neck Neoplasms - etiology | Humans | Head and Neck Neoplasms - therapy
POSTOPERATIVE CHEMORADIATION | CRITICAL-APPRAISAL | ONCOLOGY | OROPHARYNGEAL CANCER | EXTRACAPSULAR SPREAD | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | HUMAN-PAPILLOMAVIRUS | PROGNOSTIC-SIGNIFICANCE | METASTATIC HEAD | NEGATIVE HEAD | Head and Neck Neoplasms - diagnosis | Head and Neck Neoplasms - etiology | Humans | Head and Neck Neoplasms - therapy
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 10/2014, Volume 12, Issue 10, pp. 1454 - 1487
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers focuses on glottic laryngeal cancer, which is...
SQUAMOUS-CELL-CARCINOMA | STAGE NASOPHARYNGEAL CARCINOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RANDOMIZED PHASE-II | TRIAL COMPARING RADIOTHERAPY | STANDARD FRACTIONATION RADIOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | POSTOPERATIVE RADIATION-THERAPY
SQUAMOUS-CELL-CARCINOMA | STAGE NASOPHARYNGEAL CARCINOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RANDOMIZED PHASE-II | TRIAL COMPARING RADIOTHERAPY | STANDARD FRACTIONATION RADIOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | POSTOPERATIVE RADIATION-THERAPY
Journal Article